[{"orgOrder":0,"company":"University of Miami","sponsor":"Acerus Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Testosterone Cypionate","moa":"Androgen Receptor","graph1":"Endocrinology","graph2":"Phase IV","graph3":"University of Miami","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"University of Miami \/ Acerus Pharmaceuticals","highestDevelopmentStatusID":"11","companyTruncated":"University of Miami \/ Acerus Pharmaceuticals"},{"orgOrder":0,"company":"Latin American Cooperative Oncology Group","sponsor":"Bayer AG","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Testosterone Cypionate","moa":"Androgen Receptor","graph1":"Oncology","graph2":"Phase II","graph3":"Latin American Cooperative Oncology Group","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Latin American Cooperative Oncology Group \/ Bayer AG","highestDevelopmentStatusID":"8","companyTruncated":"Latin American Cooperative Oncology Group \/ Bayer AG"},{"orgOrder":0,"company":"Yale University","sponsor":"Dendreon","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Testosterone Cypionate","moa":"Androgen Receptor","graph1":"Oncology","graph2":"Phase II","graph3":"Yale University","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Yale University \/ Dendreon","highestDevelopmentStatusID":"8","companyTruncated":"Yale University \/ Dendreon"}]

Find Clinical Drug Pipeline Developments & Deals for Testosterone Cypionate

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Yale University

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          Yale University

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          October 25, 2023

                          Lead Product(s) : Testosterone Cypionate

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : Dendreon

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Latin American Cooperative Oncology Group

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          Latin American Cooperative Oncology Group

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          September 22, 2020

                          Lead Product(s) : Testosterone Cypionate

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : Bayer AG

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          University of Miami

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          University of Miami

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          June 19, 2020

                          Lead Product(s) : Testosterone Cypionate

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Phase IV

                          Sponsor : Acerus Pharmaceuticals

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          BIOHK2025
                          Not Confirmed
                          BIOHK2025
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          January 03, 2019

                          Lead Product(s) : Testosterone Cypionate

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins

                          Country arrow
                          BIOHK2025
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          June 13, 2018

                          Lead Product(s) : Testosterone Cypionate

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : Bristol Myers Squibb

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank